BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20831700)

  • 1. A case of progressive macular hypomelanosis treated with 1% topical clindamycin lotion and narrow-band ultraviolet B.
    Erpolat S; Gorpelioglu C; Sarifakioglu E
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):277-8. PubMed ID: 20831700
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
    Relyveld GN; Kingswijk MM; Reitsma JB; Menke HE; Bos JD; Westerhof W
    J Am Acad Dermatol; 2006 Nov; 55(5):836-43. PubMed ID: 17052490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of progressive macular hypomelanosis successfully treated with benzoyl peroxide plus narrow-band UVB.
    Wu XG; Xu AE; Luo XY; Song XZ
    J Dermatolog Treat; 2010 Nov; 21(6):367-8. PubMed ID: 20524876
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressive macular hypomelanosis, excellent response with narrow-band ultraviolet B phototherapy.
    Montero LC; Belinchón I; Toledo F; Betlloch I
    Photodermatol Photoimmunol Photomed; 2011 Jun; 27(3):162-3. PubMed ID: 21535172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of progressive macular hypomelanosis treated with narrow-band UVB.
    Chung YL; Goo B; Chung WS; Lee GS; Hann SK
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):1007-9. PubMed ID: 17659033
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive macular hypomelanosis.
    Elmariah SB; Kundu RV
    J Drugs Dermatol; 2011 May; 10(5):502-6. PubMed ID: 21533296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive macular hypomelanosis successfully treated with topical clindamycin and benzoyl peroxide].
    Echeverría B; Botella-Estrada R; Escutia B; Guillén C
    Actas Dermosifiliogr; 2010 Jul; 101(6):565-7. PubMed ID: 20738984
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomelanosis: a randomized, doubleblind, placebo-controlled trial.
    Santos JB; Almeida OL; Silva LM; Barreto ER
    An Bras Dermatol; 2011; 86(1):50-4. PubMed ID: 21437522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on the letter by Chung et al. about progressive macular hypomelanosis.
    Menke H; Relyveld G; Westerhof W
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1029-30. PubMed ID: 18540982
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic guttate hypomelanosis: idiopathic or ultraviolet induced?
    Kaya TI; Yazici AC; Tursen U; Ikizoglu G
    Photodermatol Photoimmunol Photomed; 2005 Oct; 21(5):270-1. PubMed ID: 16149941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
    Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
    J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and relapse rates of different treatment modalities for progressive macular hypomelanosis.
    Thng ST; Long VS; Chuah SY; Tan VW
    Indian J Dermatol Venereol Leprol; 2016; 82(6):673-676. PubMed ID: 27212282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A white woman with white skin spots].
    Vermazeren-van Roij JM; Faber WR
    Ned Tijdschr Geneeskd; 2011; 155(33):A2421. PubMed ID: 21854654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive macular hypomelanosis in a 16-year old.
    Perman M; Sheth P; Lucky AW
    Pediatr Dermatol; 2008; 25(1):63-5. PubMed ID: 18304157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive macular hypomelanosis: an overview.
    Relyveld GN; Menke HE; Westerhof W
    Am J Clin Dermatol; 2007; 8(1):13-9. PubMed ID: 17298102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive macular hypomelanosis showing excellent response to oral isotretinoin.
    Kim YJ; Lee DY; Lee JY; Yoon TY
    J Dermatol; 2012 Nov; 39(11):937-8. PubMed ID: 22724575
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progressive and confluent macular hypomelanosis].
    Rodríguez-Lojo R; Verea MM; Velasco D; Barja JM
    Actas Dermosifiliogr; 2010 Apr; 101(3):268-9. PubMed ID: 20398605
    [No Abstract]   [Full Text] [Related]  

  • 18. Fox-Fordyce disease treated with topical clindamycin solution.
    Miller ML; Harford RR; Yeager JK
    Arch Dermatol; 1995 Oct; 131(10):1112-3. PubMed ID: 7574824
    [No Abstract]   [Full Text] [Related]  

  • 19. Unsuccessful treatment of progressive macular hypomelanosis with oral isotretinoin.
    Damevska K; Pollozhani N; Neloska L; Duma S
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28631424
    [No Abstract]   [Full Text] [Related]  

  • 20. Adolescent extra-truncal progressive macular hypomelanosis.
    Paquette GM; Sherman S; Akabane A; Harris JE
    Pediatr Dermatol; 2023; 40(4):702-705. PubMed ID: 36744793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.